S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Biden To Unleash "Choke Point" Operation On America? (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
NYSE:AMCR

Amcor - AMCR Price Target & Analyst Ratings

$10.93
+0.09 (+0.83%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$10.74
$10.97
50-Day Range
$10.70
$12.20
52-Week Range
$10.42
$13.60
Volume
6.14 million shs
Average Volume
8.56 million shs
Market Capitalization
$16.24 billion
P/E Ratio
15.18
Dividend Yield
4.48%
Price Target
$12.00

Amcor Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$11.70
7.04% Upside
High Prediction$11.70
Average Prediction$11.70
Low Prediction$11.70
TypeCurrent
3/26/22 to 3/26/23
1 Month Ago
2/24/22 to 2/24/23
3 Months Ago
12/26/21 to 12/26/22
1 Year Ago
3/26/21 to 3/26/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$11.70$12.00$12.15$12.70
Predicted Upside7.04% Upside3.52% Upside7.33% Upside7.04% Upside
Get Amcor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AMCR and its competitors with MarketBeat's FREE daily newsletter.

AMCR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AMCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Amcor Stock vs. The Competition

TypeAmcorIndustrial Products CompaniesS&P 500
Consensus Rating Score
2.00
2.50
2.47
Consensus RatingHoldBuyHold
Predicted Upside7.04% Upside290.08% Upside23.66% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/8/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight
1/24/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$11.70-2.50%
10/13/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Buy
8/18/2022Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
8/18/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Underperform
7/19/2022CLSA
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
3/25/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$12.00+6.38%
8/18/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$12.00 ➝ $11.50-4.96%
2/4/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$11.00 ➝ $13.00+18.07%
2/3/2021UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
1/20/2021Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$12.00+9.59%
1/5/2021Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
9/8/2020Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
6/10/2020Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Larry Gandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral
6/1/2020Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$11.50+12.80%
(Data available from 3/26/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AMCR Price Target - Frequently Asked Questions

What is Amcor's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Amcor stock is Hold based on the current 2 sell ratings, 2 hold ratings and 2 buy ratings for AMCR. The average twelve-month price prediction for Amcor is $11.70 with a high price target of $11.70 and a low price target of $11.70. Learn more on AMCR's analyst rating history.

Do Wall Street analysts like Amcor more than its competitors?

Analysts like Amcor less than other Industrial Products companies. The consensus rating for Amcor is Hold while the average consensus rating for industrial products companies is Buy. Learn more on how AMCR compares to other companies.

Is Amcor being downgraded by Wall Street analysts?

Over the previous 90 days, Amcor's stock had 2 downgrades by analysts.

Does Amcor's stock price have much downside?

According to analysts, Amcor's stock has a predicted downside of -2.50% based on their 12-month price targets.

What analysts cover Amcor?

Amcor has been rated by JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:AMCR) was last updated on 3/26/2023 by MarketBeat.com Staff